Skip to main content
Solid Tumor Head and Neck Cancer

Head and Neck Cancer

Salivary biomarkers could predict oral cancer recurrence

Post-treatment evaluation of salivary biomarkers could be useful for monitoring recurrence in people with oral cavity or oropharyngeal cancer.

Read more

Editor's Choice

Cannabis use a risk factor for head and neck cancer

A US study has found an increased risk for head and neck cancer among people with versus without cannabis-related disorders.

Robotic surgery for head and neck tumors

What are the current applications of robotic surgery in the treatment of head and neck tumors? And how are recent advances expanding the indications to difficult-to-access regions?

Progress in immunotherapy for head and neck cancer

Surgery, radiotherapy, and chemotherapy are the primary treatments for advanced head and neck cancer, but checkpoint inhibition has recently shown promise. Delve into the efficacy and safety data for the key agents.

Management of dysphagia in head and neck cancer

Speech and language therapists play a key role in the assessment and management of dysphagia following head and neck cancer radiotherapy. What are the current therapeutic approaches and the areas of unmet need?

Our tailored content service will keep you up to date…

Receive newsletters curated for the busy specialist by our expert editorial team

2024 ESMO Congress

SPONSORED

Recent advances in the use of CAR T-cell therapies in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma

  • Live
  • Webinar | 01-10-2024 | 12:30 (CEST)

Live: Tuesday 1st October 2024, 12:30-14:00 (CEST)

In this webinar, Professor Martin Dreyling and an esteemed international panel of CAR T-cell therapy experts discuss the latest data on the safety, efficacy, and clinical impact of CAR T-cell therapies in the treatment of r/r DLBCL and r/r FL.

Please note, this webinar is not intended for healthcare professionals based in the US and UK.

Sponsored by:
  • Novartis Pharma AG
Chaired by: Prof. Martin Dreyling
Developed by: Springer Healthcare
Reserve your place now

Case Studies

An aggressive presentation of secretory carcinoma

Secretory carcinoma is generally considered a slow-growing, low-grade malignant tumor, but this report describes a patient with high-grade features who presented with a soft-tissue neck mass.

Breast metastases in a male patient with nasopharyngeal carcinoma

Nasopharyngeal carcinoma is known for its high potential to metastasize, but breast metastasis is rare. The authors describe the first case of synchronous breast metastases in a male patient.

Carcinosarcoma of the parotid gland

Carcinosarcomas or malignant mixed tumors of the salivary gland are extremely rare. This report describes the first case of adenoid cystic carcinoma as the carcinomatous component with chondrosarcoma.

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

  • Webinar | 19-02-2024 | 17:30 (CET)

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Watch now

Current Reviews

Proton Therapy in The Treatment of Head And Neck Cancers- Review

According to GLOBOCAN 2020, head and neck cancers rank as the seventh most common cancer worldwide, accounting for over 900,000 new cases annually, nearly half of which result in death. Currently, the treatment strategies for head and neck cancers …

Current Status of Partial Laryngeal Surgery for Advanced Laryngeal Cancer: When and Why?

The surgical landscape for advanced laryngeal cancer (LC) has undergone significant transformations since the first total laryngectomy, carried out in 1873, marking over 150 years of evolution toward strategies aiming to the preservation of the …

Metastatic cutaneous squamous cell carcinoma accounts for nearly all squamous cell carcinomas of the parotid gland

Primary squamous cell carcinoma of the parotid gland (pSCCP) has long been recognized as a separate entity and is included in the WHO classifications of salivary gland tumors. However, it is widely accepted among head and neck pathologists that …

The impact of margins in laryngeal cancer patients treated with transoral laser microsurgery: a systematic review and meta-analysis

The combined effect of the increased risk of head and neck cancer with advancing age, along with the improvement in life expectancy results in a marked rise in the prevalence of laryngeal squamous cell carcinoma (LSCC) [ 1 ]. Nowadays, early-stage …

Case-based insights: Oncology and hematology (Link opens in a new window)


Refresh your knowledge in oncology and hematology: 

  • 45 clinical cases across different topics with relevant clinical images
  • Written by renowned experts 
  • Knowledge-check questions with answers
Try the first set of cases now

CME & eLearning

Patient Cases

Take on interactive case studies with a focus on hematology. Each case has been prepared by renowned experts in the field and features knowledge-check questions with answers to help keep you and your practice up to date.

Developed by: Springer Medizin

Further Reading

Proton Therapy in The Treatment of Head And Neck Cancers- Review

According to GLOBOCAN 2020, head and neck cancers rank as the seventh most common cancer worldwide, accounting for over 900,000 new cases annually, nearly half of which result in death. Currently, the treatment strategies for head and neck cancers …

Cancer and immune response: The role of PD-1/PD-L1 checkpoint in laryngeal carcinoma. Preliminary results

Laryngeal squamous cell carcinoma (LSCC) is among the most prevalent head and neck cancers worldwide [ 1 ]. In the last years, despite the overall incidence of LSCC is decreased [ 2 ] and despite advancements in diagnostic tools, around 60% of LSCC …

DIAPH2 gene polymorphisms and laryngeal cancer risk in men

Laryngeal squamous cell carcinoma (LSCC) is one of the most common malignancies of the head and neck. It is a significant clinical problem because of its high incidence and the lack of effective treatment. Due to higher rates of tobacco and …

Stapler versus conventional pharyngeal repair after total laryngectomy: a randomized clinical trial

Pharyngocutaneous fistula (PCF) is the commonest complication after total laryngectomy [ 1 ]. It develops as a result of leakage of saliva through the pharyngeal repair line [ 2 , 3 ]. PCF contributes to increased morbidity following laryngectomy …